Showing results (201-210 of 413) with videos related to

Sort By:
Pageof 42
Urologic Oncology|July 31, 2004
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncologyWilliam E Grizzle, O John Semmes, Joseph Basler, et al.
The Prostate|November 7, 2017
Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancerHeather H Cheng, Melissa Plets, Hongli Li, et al.
Prostate Cancer and Prostatic Diseases|February 15, 2020
Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancerRisa L Wong, Mai T Duong, Catherine M Tangen, et al.
The Journal of Urology|January 27, 2009
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trialIan M Thompson, Catherine M Tangen, Jorge Paradelo, et al.
The Journal of Urology|October 24, 2002
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109Isaac J Powell, Catherine M Tangen, Gary J Miller, et al.
JAMA Network Open|August 1, 2023
Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG 1216 Phase 3 TrialNicolas Sayegh, Umang Swami, Yeonjung Jo, et al.
BMC Urology|March 30, 2022
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trialsJonathan A Gelfond, Brian Hernandez, Martin Goros, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 19, 2019
Electronic care coordination systems for people with advanced progressive illness: a mixed-methods evaluation in Scottish primary careAnne M Finucane, Deborah Davydaitis, Zoe Horseman, et al.
Urology|May 28, 2014
Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancerDonna P Ankerst, Josef Hoefler, Sebastian Bock, et al.
European Urology Focus|February 10, 2018
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk CalculatorDonna P Ankerst, Martin Goros, Scott A Tomlins, et al.
Pageof 42